Egg-cellent idea: can two eggs a day rebuild cancer Survivors' muscles?
NCT ID NCT05859100
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether eating at least two eggs daily can help cancer survivors restore lost muscle and improve their quality of life after treatment. Only 2 people took part, making it a very small feasibility trial. Researchers measured protein intake, body weight, and overall well-being over 8 weeks. The goal was to see if a simple whole-food approach could meet protein needs better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
2 people
The number who actually took part.
- Started
-
Sep 2023
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients must have the ability to read, understand, and sign an informed consent and must be willing to comply with study treatment and follow-up. * ≥18 years of age * Histopathologically confirmed cancer with receipt of a platinum chemotherapy during treatment; active treatment has concluded. * Capable of volitional oral semi-solid intake at baseline; able to maintain oral intake over the trial. Exclusion Criteria: * Fed by nasogastric tube, gastrostomy, or total parenteral nutrition * Cancer of the brain, Cancer of the regions which impact an individual's ability to consume food. * A known hypersensitivity / allergy to eggs. * Enrolment in any other clinical protocol or investigational study that may interfere with study procedures. * Poorly controlled chronic illnesses or other inflammatory diseases (e.g. Chronic Obstructive Pulmonary Disease(COPD), uncontrolled non-insulin dependent diabetes, rheumatoid arthritis). * In a clinician opinion, patients who have medical conditions that could interfere with nutrient metabolism or absorption (e.g., short bowel syndrome, Crohn's disease, etc.)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alberta
Edmonton, Alberta, T6G 2C8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?